Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Crabtree TSJ, et al. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. Diabetes Care. 2023. PMID: 37566697 Free PMC article.
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
Ryder REJ, Laubner K, Benes M, Haluzik M, Munro L, Frydenberg H, Teare JP, Ruban A, Fishman S, Santo E, Stengel R, De Jonge C, Greve JW, Cohen RV, Aboud CM, Holtmann GJ, Rich G, McMaster JJ, Battelino T, Kotnik P, Byrne JP, Mason JC, Bessell J, Bascomb J, Kow L, Collins J, Chisholm J, Pferschy PN, Sourij H, Cull ML, Wyres MC, Drummond R, McGowan B, Amiel SA, Yadagiri M, Sen Gupta P, Aberle J, Seufert J. Ryder REJ, et al. Among authors: cull ml. Diabetes Care. 2023 Apr 1;46(4):e89-e91. doi: 10.2337/dc22-1952. Diabetes Care. 2023. PMID: 36716004 Free PMC article. No abstract available.
Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits.
Thong KY, Ryder RE, Cull ML, Walton C; ABCD Nationwide Exenatide and Liraglutide Audit Contributors. Thong KY, et al. Among authors: cull ml. Diabet Med. 2012 May;29(5):690-2. doi: 10.1111/j.1464-5491.2011.03475.x. Diabet Med. 2012. PMID: 21988449 No abstract available.
Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*.
Thong KY, Jose B, Sukumar N, Cull ML, Mills AP, Sathyapalan T, Shafiq W, Rigby AS, Walton C, Ryder RE; ABCD Nationwide Exenatide Audit Contributors. Thong KY, et al. Among authors: cull ml. Diabetes Obes Metab. 2011 Aug;13(8):703-10. doi: 10.1111/j.1463-1326.2011.01393.x. Diabetes Obes Metab. 2011. PMID: 21410858